RECRUITING · INTERVENTIONAL · TREATMENT study · Pemphigus · Phase 3 · Enrollment 34 · Sponsor: Ono Pharmaceutical Co. Ltd
Official title: ONO-4059-10:Multicenter, Placebo-controlled, Randomized, Double-blind, Phase 3 Study in Patients With Steroid-resistant Pemphigus (BRILLIANT Study)
Summary: ONO-4059-10:Multicenter, placebo-controlled, randomized, double-blind, Phase 3 study in patients with steroid-resistant pemphigus
Conditions: Pemphigus, Steroid-resistant Pemphigus
Study type: INTERVENTIONAL
Primary purpose: TREATMENT
Phases: PHASE3
Enrollment: 34 (ESTIMATED)
Status: RECRUITING
Completion: 2029-03-31 (ESTIMATED)